CN Patent

CN116970028A — 大环拟肽类蛋白酶抑制剂及其用途

Assigned to Tencent Technology Shenzhen Co Ltd · Expires 2023-10-31 · 3y expired

What this patent protects

本申请提出了一种化合物，其为式(I)所示化合物或式(I)所示化合物的立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐或它的前药，式(I)所示的化合物能够显著抑制Mpro或抑制冠状病毒复制，并且具有很好的代谢稳定性。

USPTO Abstract

本申请提出了一种化合物，其为式(I)所示化合物或式(I)所示化合物的立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐或它的前药，式(I)所示的化合物能够显著抑制Mpro或抑制冠状病毒复制，并且具有很好的代谢稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN116970028A
Jurisdiction
CN
Classification
—
Expires
2023-10-31
Drug substance claim
No
Drug product claim
No
Assignee
Tencent Technology Shenzhen Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.